These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 7333060

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Monthly variations in the clearance of antipyrine in the rat.
    Bélanger PM, Doré F, Labrecque G.
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):53-65. PubMed ID: 6505390
    [Abstract] [Full Text] [Related]

  • 23. Alprazolam kinetics in the elderly. Relation to antipyrine disposition.
    Greenblatt DJ, Divoll M, Abernethy DR, Moschitto LJ, Smith RB, Shader RI.
    Arch Gen Psychiatry; 1983 Mar; 40(3):287-90. PubMed ID: 6131657
    [Abstract] [Full Text] [Related]

  • 24. Age, sex, and nitrazepam kinetics: relation to antipyrine disposition.
    Greenblatt DJ, Abernethy DR, Locniskar A, Ochs HR, Harmatz JS, Shader RI.
    Clin Pharmacol Ther; 1985 Dec; 38(6):697-703. PubMed ID: 4064471
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV, Sotaniemi EA.
    Eur J Drug Metab Pharmacokinet; 1981 Dec; 6(4):261-4. PubMed ID: 7333326
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Physical exercise and improvement of liver oxidative metabolism in the elderly.
    Mauriz JL, Tabernero B, García-López J, Jorquera F, Villa JG, González-Gallego J.
    Eur J Appl Physiol; 2000 Jan; 81(1-2):62-6. PubMed ID: 10552268
    [Abstract] [Full Text] [Related]

  • 29. Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine disposition.
    Greenblatt DJ, Divoll MK, Abernethy DR, Ochs HR, Harmatz JS, Shader RI.
    Pharmacology; 1989 Jan; 38(5):327-34. PubMed ID: 2762375
    [Abstract] [Full Text] [Related]

  • 30. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in uraemic rabbits.
    Van Peer AP, Belpaire FM, Bogaert MG.
    J Pharm Pharmacol; 1980 Feb; 32(2):135-6. PubMed ID: 6103036
    [No Abstract] [Full Text] [Related]

  • 31. Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis.
    Bauer LA, O'Sullivan T, Reiss WG, Horn JR, Opheim K, Strandness DE, Carithers RL.
    Br J Clin Pharmacol; 1994 Apr; 37(4):375-81. PubMed ID: 8018459
    [Abstract] [Full Text] [Related]

  • 32. Interaction between metronidazole and drugs eliminated by oxidative metabolism.
    Jensen JC, Gugler R.
    Clin Pharmacol Ther; 1985 Apr; 37(4):407-10. PubMed ID: 3979002
    [Abstract] [Full Text] [Related]

  • 33. Cholestasis and hepatic drug metabolism. Comparison of metabolic clearance rate of antipyrine in patients with intrahepatic or extrahepatic cholestasis.
    Miguet JP, Vuitton D, Deschamps JP, Allemand H, Joanne C, Bechtel P, Carayon P.
    Dig Dis Sci; 1981 Aug; 26(8):718-22. PubMed ID: 7261836
    [Abstract] [Full Text] [Related]

  • 34. Antipyrine clearance in congenital adrenal hyperplasia.
    Loche S, Rifkind AB, Stoner E, Conney AH, New MI.
    Clin Endocrinol (Oxf); 1986 Sep; 25(3):233-9. PubMed ID: 3791665
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D, Miguet JP, Camelot G, Delafin C, Joanne C, Bechtel P, Gillet M, Carayon P.
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [Abstract] [Full Text] [Related]

  • 37. Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance.
    Elin RJ, Vesell ES, Wolff SM.
    Clin Pharmacol Ther; 1975 Apr; 17(4):447-57. PubMed ID: 1122686
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.